Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats.
Adamy C, Mulder P, Khouzami L, Andrieu-abadie N, Defer N, Candiani G, Pavoine C, Caramelle P, Souktani R, Le Corvoisier P, Perier M, Kirsch M, Damy T, Berdeaux A, Levade T, Thuillez C, Hittinger L, Pecker F.
Adamy C, et al. Among authors: kirsch m.
J Mol Cell Cardiol. 2007 Sep;43(3):344-53. doi: 10.1016/j.yjmcc.2007.06.010. Epub 2007 Jun 30.
J Mol Cell Cardiol. 2007.
PMID: 17707397